IS8222A - Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity - Google Patents

Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity

Info

Publication number
IS8222A
IS8222A IS8222A IS8222A IS8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A IS 8222 A IS8222 A IS 8222A
Authority
IS
Iceland
Prior art keywords
restore
organs
tissues
tissue
protect
Prior art date
Application number
IS8222A
Other languages
Icelandic (is)
Inventor
Cerami Anthony
Brines Michael
Coleman Thomas
Original Assignee
The Kenneth S. Warren Institute, Inc.
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Kenneth S. Warren Institute, Inc., H. Lundbeck A/S filed Critical The Kenneth S. Warren Institute, Inc.
Publication of IS8222A publication Critical patent/IS8222A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS8222A 2004-05-20 2006-01-10 Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity IS8222A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/015863 WO2005117927A2 (en) 2004-05-20 2004-05-20 Tissue protective cytokines with an extended therapeutic window

Publications (1)

Publication Number Publication Date
IS8222A true IS8222A (en) 2006-01-10

Family

ID=35463339

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8222A IS8222A (en) 2004-05-20 2006-01-10 Tissue-protecting cell messengers to protect, restore and improve responsive cells, tissues and organs, and to have extended therapeutic capacity

Country Status (7)

Country Link
CN (1) CN1897960A (en)
AU (1) AU2004319797A1 (en)
BR (1) BRPI0412869A (en)
IL (1) IL172036A0 (en)
IS (1) IS8222A (en)
NO (1) NO20062506L (en)
WO (1) WO2005117927A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718363B2 (en) 2003-04-25 2010-05-18 The Kenneth S. Warren Institute, Inc. Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
WO2019072411A1 (en) * 2017-10-10 2019-04-18 Augustinus Bader Erythropoietin (epo) application in spinal cord injury (sci) therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300915B2 (en) * 2002-06-05 2007-11-27 The Regents Of The University Of California Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
US20040091961A1 (en) * 2002-11-08 2004-05-13 Evans Glen A. Enhanced variants of erythropoietin and methods of use
EP1633383A4 (en) * 2003-03-27 2008-05-21 Janssen Pharmaceutica Nv Use of erythropoietin in stroke recovery

Also Published As

Publication number Publication date
AU2004319797A8 (en) 2008-12-11
WO2005117927A3 (en) 2006-05-11
BRPI0412869A (en) 2006-10-03
AU2004319797A1 (en) 2006-01-12
IL172036A0 (en) 2009-02-11
WO2005117927A2 (en) 2005-12-15
CN1897960A (en) 2007-01-17
NO20062506L (en) 2006-05-31

Similar Documents

Publication Publication Date Title
IS7604A (en) Transformed tissue-protective cell messengers and nucleic acids that represent them, acts to protect, repair, and improve responsive cells, tissues, and organs
DK2921500T5 (en) GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
IS8075A (en) Tissue Receptor Cell Prototype, Tests to Identify Tissue Protective Compounds and Their Use
IL164079A0 (en) Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
WO2008048620A3 (en) Gels with predetermined conductivity used in irreversible electroporation of tissue
DE112004002289D2 (en) Electrochemical battery cell
FR2870387B1 (en) ELECTROCHEMICAL ENERGY ACCUMULATOR
IS8156A (en) Tissue protective cells to protect, restore, and improve responsive cells, tissues and organs, and have extended therapeutic capacity
GB0416708D0 (en) Improvements relating to electrode structures in batteries
EP2210622A4 (en) THERAPEUTIC AGENT FOR CARDIAC DISEASES FOR USE IN CELL TRANSPLANT THERAPY
IL187491A0 (en) Controlled electroporation and mass treansfer across cell membranes in tissue
EP1851814A4 (en) ACCUMULATOR HAVING ION-LITHIUM MOBILITY AND ENHANCED CELL CAPACITY
PT2203176E (en) TUMOR SUPPRESSION USING HUMAN PLACENTARY PERFUSION AND INTERMEDIATE NATURAL MURDER CELLS DERIVED FROM HUMAN PLACENTA
EP1809740A4 (en) CARDIAC STEM CELLS
SI1926813T2 (en) Cell population with immunoregulatory activity, isolation and administration procedure
DK2730277T3 (en) Drug carrier and drug carrier kit to inhibit fibrosis
IL242645B (en) Angiogenic cells from human placental perfusate
PT2205721T (en) TR1 CELLS, MESENQUIMIAL TRUNK CELLS AND USES OF THE SAME
DE602006018990D1 (en) MEMBRANE ELECTROLYTE AND CONNECTING PRODUCT AND FESTPOLYMER ELECTROLYTE FUEL BATTERY
EP1629557A4 (en) MATRIX ELECTROLYTE POLYIMIDE
DK1937276T3 (en) IMPROVED TESTOSTERONGEL AND PROCEDURE TO USE THEREOF
ZA200703293B (en) Cell bandage
IS8090A (en) Composition to improve wit and memory
WO2007025166A3 (en) Devices, compositions and methods for the protection and repair of cells and tissues
DE602004010307D1 (en) USE OF POLYSULPATED ALGINATE IN CELL MATRIX